Carnosine and derivatives as a potential therapeutic agents for neurodegenerative diseases

- 343186
Poster Presentation
Favorite this paper
How to cite this paper?
Abstract

Carnosine is an endogenous dipeptide and deserves huge interest due to its biological and chemical properties, particularly its role as a chelate of metal ions and antioxidant agent. Antioxidant agents are essential in suppressing oxidative damage to biomolecules caused mainly by reactive species, although produced by physiological processes, they are also active in many pathogeneses such as neurodegenerative disorders. Evidence suggests that carnosine may act in therapy for many diseases, however, current research reports the use of carnosine in high concentrations and prolonged incubation period for in vitro assays to achieve significant IC50 values in anticancer studies. Consequently, there is a demand for more potent carnosine analogues with improved biochemical properties. This study investigates the possible therapeutic potential of carnosine derivatives. The principal aim is to evaluate their efficacy in inhibiting the aggregation of Aβ1-40 peptides.

 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 University of São Paulo
  • 2 Universidade de São Paulo (USP)
  • 3 Chemistry Institute of University of Sao Paulo
Track
  • TL03 - Biological and Medicinal Inorganic Chemistry
Keywords
carnosine
chelate agent
antioxidant agent